National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer

作者: Kristin A. Higgins , Kelli O'Connell , Yuan Liu , Theresa W. Gillespie , Mark W. McDonald

DOI: 10.1016/J.IJROBP.2016.10.001

关键词:

摘要: Purpose To analyze outcomes and predictors associated with proton radiation therapy for non-small cell lung cancer (NSCLC) in the National Cancer Database. Methods Materials The Database was queried to capture patients stage I-IV NSCLC treated thoracic from 2004 2012. A logistic regression model used determine utilization of therapy. univariate multivariable association overall survival were assessed by Cox proportional hazards models along log–rank tests. propensity score matching method implemented balance baseline covariates eliminate selection bias. Results total 243,822 (photon therapy: 243,474; 348) included analysis. Patients a ZIP code median income P =.011). On multivariate analysis all patients, non-proton significantly worse compared (hazard ratio 1.21 [95% CI 1.06-1.39]; =.025). For II III 1.35 1.10-1.64], Conclusions Thoracic protons is better this retrospective analysis; further validation randomized setting needed account any imbalances patient characteristics, including positron emission tomography–computed tomography staging.

参考文章(20)
Quynh-Nhu Nguyen, Ngoc Bui Ly, Ritsuko Komaki, Lawrence B. Levy, Daniel R. Gomez, Joe Y. Chang, Pamela K. Allen, Reza J. Mehran, Charles Lu, Michael Gillin, Zhongxing Liao, James D. Cox, Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer Radiotherapy and Oncology. ,vol. 115, pp. 367- 372 ,(2015) , 10.1016/J.RADONC.2015.05.014
Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara, Hideki Nishikawa, Yoshiki Takada, Shinzoh Kudoh, Nobuyuki Katagami, Yutaka Ariyoshi, Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2692- 2692 ,(1999) , 10.1200/JCO.1999.17.9.2692
Anthony Magliocco, Vivek Kavadi, Yolanda I Garces, Samir Narayan, Puneeth Iyengar, Cliff Robinson, Raymond B Wynn, Christopher Koprowski, Joanne Meng, Jonathan Beitler, Rakesh Gaur, Walter Curran, Hak Choy, Jeffrey D Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory Masters, George Blumenschein, Steven Schild, Jeffrey Bogart, Chen Hu, Kenneth Forster, Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Lancet Oncology. ,vol. 16, pp. 187- 199 ,(2015) , 10.1016/S1470-2045(14)71207-0
David S Ettinger, Douglas E Wood, Wallace Akerley, Lyudmila A Bazhenova, Hossein Borghaei, David Ross Camidge, Richard T Cheney, Lucian R Chirieac, Thomas A D’Amico, Todd L Demmy, Thomas J Dilling, M Chris Dobelbower, Ramaswamy Govindan, Frederic W Grannis, Leora Horn, Thierry M Jahan, Ritsuko Komaki, Lee M Krug, Rudy P Lackner, Michael Lanuti, Rogerio Lilenbaum, Jules Lin, Billy W Loo, Renato Martins, Gregory A Otterson, Jyoti D Patel, Katherine M Pisters, Karen Reckamp, Gregory J Riely, Eric Rohren, Steven E Schild, Theresa A Shapiro, Scott J Swanson, Kurt Tauer, Stephen C Yang, Kristina Gregory, Miranda Hughes, None, Non–Small Cell Lung Cancer, Version 6.2015 Journal of The National Comprehensive Cancer Network. ,vol. 13, pp. 515- 524 ,(2015) , 10.6004/JNCCN.2015.0071
D. Y. Lin, L. J. Wei, The Robust Inference for the Cox Proportional Hazards Model Journal of the American Statistical Association. ,vol. 84, pp. 1074- 1078 ,(1989) , 10.1080/01621459.1989.10478874
Matthew J. Bott, Aalok P. Patel, Traves D. Crabtree, Daniel Morgensztern, Clifford G. Robinson, Graham A. Colditz, Saiama Waqar, Daniel Kreisel, A. Sasha Krupnicka, G. Alexander Patterson, Stephen Broderick, Bryan F. Meyers, Varun Puri, Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non–Small Cell Lung Cancer The Annals of Thoracic Surgery. ,vol. 99, pp. 1921- 1928 ,(2015) , 10.1016/J.ATHORACSUR.2015.02.033
Anne Aupérin, Cecile Le Péchoux, Estelle Rolland, Walter J. Curran, Kiyoyuki Furuse, Pierre Fournel, Jose Belderbos, Gerald Clamon, Hakki Cuneyt Ulutin, Rebecca Paulus, Takeharu Yamanaka, Marie-Cecile Bozonnat, Apollonia Uitterhoeve, Xiaofei Wang, Lesley Stewart, Rodrigo Arriagada, Sarah Burdett, Jean-Pierre Pignon, Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 28, pp. 2181- 2190 ,(2010) , 10.1200/JCO.2009.26.2543
Pierre Fournel, Gilles Robinet, Pascal Thomas, Pierre-Jean Souquet, Hervé Léna, Alain Vergnenégre, Jean-Yves Delhoume, Jacques Le Treut, Jules-Antoine Silvani, Eric Dansin, Marie-Cécile Bozonnat, Jean-Pierre Daurés, Françoise Mornex, Maurice Pérol, Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study Journal of Clinical Oncology. ,vol. 23, pp. 5910- 5917 ,(2005) , 10.1200/JCO.2005.03.070
Aileen B. Chen, Bridget A. Neville, David J. Sher, Kun Chen, Deborah Schrag, Survival Outcomes After Radiation Therapy for Stage III Non–Small-Cell Lung Cancer After Adoption of Computed Tomography–Based Simulation Journal of Clinical Oncology. ,vol. 29, pp. 2305- 2311 ,(2011) , 10.1200/JCO.2010.33.4466
Chandra P. Belani, Hak Choy, Phil Bonomi, Charles Scott, Patrick Travis, John Haluschak, Walter J. Curran, Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol Journal of Clinical Oncology. ,vol. 23, pp. 5883- 5891 ,(2005) , 10.1200/JCO.2005.55.405